|
000
| 02056cam 2200385zi 4500 |
|---|
| 001 | 9.859811 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107160335 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 180730t20192019onc o f000 0 eng d |
|---|
| 020 | |a9780660274355 |
|---|
| 040 | |aCaOODSP|beng|erda|eCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH13-9/18-2019E-PDF |
|---|
| 245 | 00|aGuidance document : |bfees for the review of human and disinfectant drug submissions and applications. |
|---|
| 246 | 17|aFees for the review of human and disinfectant drug submissions and applications |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2019. |
|---|
| 264 | 4|c©2019 |
|---|
| 300 | |a1 online resource (21 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Ligne directrice : frais pour l'examen des présentations et des demandes de médicaments à usage humain et de désinfectants assimilés à une drogue. |
|---|
| 500 | |a"Publication date: November 2019." |
|---|
| 500 | |a"Pub.: 180194." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 520 | |a"This document provides guidance on how fees for the review of human and disinfectant drug submissions and applications will be administered in accordance with the Food and Drugs Act and as stipulated in the Fees in Respect of Drugs and Medical Devices Order and the Regulations Amending and Repealing Certain Regulations Made under the Financial Administration Act"--Objectives, page 6. |
|---|
| 650 | 0|aDrug approval|zCanada. |
|---|
| 650 | 0|aFees, Administrative|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLigne directrice : |w(CaOODSP)9.859813 |
|---|
| 856 | 40|qPDF|s306 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H13-9-18-2019-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fees/fees-review-drug-submissions-applications-2019/document.html |
|---|